Table 5.
Progress of Child–Pugh score in the studied groups after 1, 2, 3, 6, 9 and 12 months of infusion
| Child–Pugh A | Child–Pugh B | Child–Pugh C | χ2 | P value | ||||
|---|---|---|---|---|---|---|---|---|
| Single infusion | Double infusion | Single infusion | Double infusion | Single infusion | Double infusion | |||
| Pre-treatment | 0 (0) | 0 (0) | 12 (40) | 18 (60) | 18 (60) | 12 (40) | 9.73 | 0.259 |
| 1 month | 0 (0) | 1 (3.3) | 22 (73.3) | 26 (86.7) | 8 (26.7) | 3 (10) | 4.72 | 0.03 |
| 2 months | 0 (0) | 1 (3.3) | 24 (80) | 28 (93.3) | 6 (20) | 1 (3.3) | 4.59 | 0.03 |
| 3 months | 1 (3.3) | 3 (10) | 25 (83.3) | 27 (90) | 3 (10) | 0 (0) | 1.03 | 0.03 |
| 6 months | 1 (3.3) | 7 (23.3) | 24 (80) | 23 (76.7) | 3 (10) | 0 (0) | 1.43 | 0.03 |
| 9 months | 0 (0) | 8 (26.7) | 24 (80) | 21 (70) | 4 (13.3) | 0 (0) | 1.54 | 0.04 |
| 12 months | 0 (0) | 7 (23.3) | 23 (76.7) | 20 (67) | 4 (13.3) | 1 (3.3) | 3.37 | 0.05* |
Data presented as count (%)
*There is a statistically significant difference between the repeated-infusion and the single-infusion groups (P ≤0.05)